Fundacion de Investigacion

San Juan 00927-4807

0 studies enrolling now · 7 studies all time

What they study most

Advanced Cancer, Liver Fibrosis Due to NASH, Lymphoma, Diffuse Large B-Cell, Non Alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease, Pan Tumor, Prediabetic State, Type 2 Diabetes Mellitus

Studies at this site

• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) — Completed
• PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) — Completed
• A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread — Completed
• ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD — Completed
• Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) — Stopped early
• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH — Stopped early